2024/10/18 08:08:13 | |
---|---|
Price | |
26.20 EUR | |
Difference | 1.31% (0.34) |
ISIN | JP3463000004 |
Symbol | 4502 |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 41,693 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 26.12 EUR (381) |
Ask (Ask size) | 26.46 EUR (377) |
Open | 26.20 EUR |
High | 26.20 EUR |
Low | 26.20 EUR |
Close (prev. day) | 25.86 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 08:08:13 | |
---|---|
Price | |
26.20 EUR | |
Difference | 1.31% (0.34) |
ISIN | JP3463000004 |
Symbol | 4502 |
Exchange | Berlin |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 41,693 EUR |
Benchmark | NIKKEI 225 |
Bid (Bid size) | 26.12 EUR (381) |
Ask (Ask size) | 26.46 EUR (377) |
Open | 26.20 EUR |
High | 26.20 EUR |
Low | 26.20 EUR |
Close (prev. day) | 25.86 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +5.90% | -5.55% | +7.38% |
Perf (abs.) | +1.46 | -1.54 | +1.80 |
Beta | 0.33 | 0.32 | 0.40 |
Volatility | 19.11 | 18.60 | 17.97 |
Ø price 5 days | Ø volume 5 days (pcs.) | 25.90 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 26.17 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 25.46 EUR (4) |
Ø price 250 days | Ø volume 250 days (pcs.) | 25.66 EUR (3) |
YTD High | date | 27.71 EUR (2024/01/15) |
YTD Low | date | 23.56 EUR (2024/06/20) |
52 Weeks High | date | 27.71 EUR (2024/01/15) |
52 Weeks Low | date | 23.56 EUR (2024/06/20) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 26.06 EUR | 0.00 | 5 |
Tradegate | 2024/10/18 | 22:26 | 26.26 EUR | 0.02 | 9 |
Tokyo Stock Exchange | 2024/10/18 | 08:00 | 4,276.00 JPY | 144.10 | 3,739 |
Stuttgart | 2024/10/18 | 08:07 | 26.09 EUR | 0.00 | 3 |
Sapporo Stock Exchange | 2024/03/11 | 01:53 | 4,300.00 JPY | 0.01 | 2 |
Munich | 2024/10/18 | 08:05 | 26.20 EUR | 0.00 | 2 |
London Stock Exchange | 2019/03/26 | 12:28 | 37.59 EUR | 0.00 | 1 |
Hanover | 2024/10/18 | 17:25 | 25.76 EUR | 0.00 | 4 |
Hamburg | 2024/10/18 | 17:25 | 25.81 EUR | 0.00 | 4 |
Fukuoka Stock Exchange | 2024/04/17 | 02:25 | 4,080.00 JPY | 0.00 | 1 |
Frankfurt | 2024/10/18 | 09:27 | 26.18 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/10/14 | 20:05 | 28.25 USD | 0.03 | 4 |
Duesseldorf | 2024/10/18 | 19:31 | 25.99 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 08:08 | 26.20 EUR | 0.00 | 2 |
TAKEDA PHARMACEUTICAL CO. LTD. |
- - |
4-1-1 Dosho-machi, Chuo-Ku - 540-8645 Osaka |
Telefon: +81-6-6204-2111 |
Fax: +81-6-6204-2880 |
E-mail: - |
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. |
Christophe Weber | Chairman of Managing Board |
Andrew Plump | Member of Executive Committee |
Costa Saroukos | Member of Executive Committee |
Gabriele Ricci | Member of Executive Committee |
Giles Platford | Member of Executive Committee |
Julie Kim | Member of Executive Committee |
Koki Sato | Member of Executive Committee |
Lauren Duprey | Member of Executive Committee |
Marcello Agosti | Member of Executive Committee |
Milano Furuta | Member of Executive Committee |
Mwana Lugogo | Member of Executive Committee |
Ramona Sequeira | Member of Executive Committee |
Takako Ohyabu | Member of Executive Committee |
Teresa Bitetti | Member of Executive Committee |
Thomas Wozniewski | Member of Executive Committee |
Yoshihiro Nakagawa | Member of Executive Committee |
Masami Iijima | Chairman of Supervisory Board |
Andrew Plump | Member of Supervisory Board |
John Maraganore | Member of Supervisory Board |
Steven Gillis | Member of Supervisory Board |
Emiko Higashi | Member of Supervisory Board |
Ian Clark | Member of Supervisory Board |
Jean-Luc Butel | Member of Supervisory Board |
Kimberly Reed | Member of Supervisory Board |
Koji Hatsukawa | Member of Supervisory Board |
Michel Orsinger | Member of Supervisory Board |
Miki Tsusaka | Member of Supervisory Board |
Milano Furuta | Member of Supervisory Board |
Yoshiaki Fujimori | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer